Brief: Kamada Receives Positive Scientific Advice From European Medicines Agency
10/07/2018 12:27
July 10 (Reuters) - Kamada Ltd KMDA.TA :
* KAMADA RECEIVES POSITIVE SCIENTIFIC ADVICE FROM EUROPEAN
MEDICINES AGENCY ON A NEW PHASE 3 STUDY DESIGN FOR INHALED AAT
Source text for Eikon: ID:nGNX6bQHk
Further company coverage: KMDA.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kamada
See all newsBrief: Kamada Updates On Withholding Tax Procedures On Previously Announced Cash Dividend To Shareholders
Brief: Kamada Announces Planned Transition Of Chief Financial Officer
Brief: Kamada Q2 EPS USD 0.16
Brief: Kamada Announces FDA Approval Of Its New In-House Rabies Virus Neutralization Testing Laboratory
Brief: Kamada Q4 EPS USD 0.06